|
|
||||||||
From the Institute of Experimental Medicine and Biotechnology (Drs. Muglia, Gabriele, Conforti, Mazzei, Patitucci, Oliveri, Gambardella, and Quattrone), National Research Council, Piano Lago di MangoneCosenza; Institute of Neurology (Drs. Zappia, Valentino, Oliveri, Bono, Gambardella, and Quattrone), School of Medicine, Catanzaro; Institute of Neurology (Dr. Ragno), Hospital G. e C. Mazzoni, Ascoli Piceno; Institute of Neurology (Dr. Sabatelli), Catholic University, Rome, Italy; and Flanders Interuniversity Institute for Biotechnology (VIB) (Dr. Timmerman), BornBunge Foundation (BBS), University of Antwerpen (UIA), Antwerpen, Belgium.
Address correspondence and reprint requests to Prof. Aldo Quattrone, Cattedra ed U.O. di Neurologia, Facoltà di Medicina e Chirurgia "Magna Graecia," Via Tommaso Campanella, 88100 Catanzaro, Italy; e-mail: neurol.unicz{at}interbusiness.it
The authors report a large pedigree from southern Italy with CharcotMarieTooth disease type 2A (CMT2A). The clinical picture was uniform and characterized by distal muscular weakness and atrophy in the lower limbs, reduced or absent tendon reflexes mainly in the lower limbs, and mild sensory impairment in the feet. Significant linkage to the CMT2A locus on chromosome 1p35p36 was detected. Based on informative recombination in affected individuals, the authors mapped the CMT2A gene between D1S160 and D1S170.
This article has been cited by other articles:
![]() |
R. D. Bo, M. Moggio, M. Rango, S. Bonato, M. G. D'Angelo, S. Ghezzi, G. Airoldi, M. T. Bassi, M. Guglieri, L. Napoli, et al. Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction Neurology, December 9, 2008; 71(24): 1959 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Chung, S. B. Kim, K. D. Park, K. G. Choi, J. H. Lee, H. W. Eun, J. S. Suh, J. H. Hwang, W. K. Kim, B. C. Seo, et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations Brain, August 1, 2006; 129(8): 2103 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H. Lawson, B. V. Graham, and K. M. Flanigan Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene Neurology, July 26, 2005; 65(2): 197 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bissar-Tadmouri, E. Nelis, S. Zuchner, Y. Parman, F. Deymeer, P. Serdaroglu, P. De Jonghe, V. Van Gerwen, V. Timmerman, J. M. Schroder, et al. Absence of KIF1B mutation in a large Turkish CMT2A family suggests involvement of a second gene Neurology, May 11, 2004; 62(9): 1522 - 1525. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |